In this episode of the COVID-19 Digest, we revisit the airborne vs droplet transmission debate and analyze a highly publicized study on Remdesivir from the New England Journal of Medicine.

Host: Elizabeth Esty, MD & Dylan Luyten, MD

Research By: Tanisha Crosby-Attipoe & Nathan Novotny

Sound Editing By: Stephen Bahmani

Time Stamps:

0:00 - Numbers

0:58 - "Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center"

6:53 - "Compassionate Use of Remdesivir for Patients with Severe Covid-19"

References:

[1] Santarpia, J. L., Rivera, D. N., Herrera, V., Morwitzer, M. J., Creager, H., Santarpia, G. W., Lowe, J. J. (2020). Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center doi:10.1101/2020.03.23.20039446

[2]Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. New England Journal of Medicine. 2020;0(0):.doi:10.1056/NEJMoa2007016

COVID-19 Digest: Airborne Transmission / Remdesivir (Recorded 4/14/20)